U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901283) titled 'Comparative Analysis of Intralesional Platelet-Rich Plasma, NPH Insulin, and Vitamin C- A New Horizon and Future Hope for Linear Atrophic Scar Management' on Oct. 22.

Brief Summary: The aim of this clinical trial is to evaluate the efficacy and safety of platelet-rich plasma, insulin and vitamin C in the management of linear atrophic scars. The participants were allocated randomly into one of the three groups. The patients will be evaluated at the end of the follow-up period together with assessment of skin thickness using ultrasound before treatment and at the end of follow-up.

Each patient received four treatment sessions at two-...